At a glance
ClinicalIndex Comparison RecordN/ACompleted· 42 enrolled
Drug / intervention
Oral Glucosebiological
Likely dose
Oral Glucose 1.75gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Frequency of Occurrence of Dumping Syndrome After Operation of Esophageal Atresia Type III
In Brief
A clinical study evaluating Oral Glucose for Oesophageal Atresia and Dumping Syndrome. Completed, enrolled 42 participants across 10 sites.
Detailed Summary
The purpose of this study is to evaluate the prevalence at 3.5 months of age of dumping syndrome in children operated at birth for oesophageal atresia type III et IV.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOesophageal Atresia, Dumping Syndrome
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
First PostedAug 2015
Primary CompletionJan 2018
TodayJul 2026
First PostedAug 17, 2015
Enrollment StartJun 14, 2011
Primary CompletionJan 15, 2018
TodayJul 2, 2026
Enrollment to primary: 6.6 yearsPosted 10.9 years ago
Interventions
Oral Glucosebiological
1.75g/kg of glucose is orally taken by the patient. Capillary glycemia is systematically realised before ingestion (H0) and after 30, 60, 90, 120, 180 and 240 min and/or if clinical signs of hypoglycemia are presented by the patient.